Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular accessibility of dabigatran after oral administration in retinal detachment
2014-000388-41Phase 2Completed
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dabigatran in retinal detachment, sponsored by Het Oogziekenhuis Rotterdam. Primary endpoints: Intraocular and plasma dabigatran concentrations and Thrombin-inhibiting activity in ocular fluids. Started Mar 2014; status: completed.
02
Drugs
dabigatran
03
Conditions
retinal detachment
Beyond the preview
Go deeper on 2014-000388-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000388-41.